FF
Insider selling
Foundation Fighting Blindness Retinal Degeneration Fund sold $2.8M of Opus Genetics, Inc. (IRD) stock
Foundation Fighting Blindness Retinal Degeneration Fund, Dir of Opus Genetics, Inc. (IRD), sold 556,000 shares of IRD stock worth $2.8M, per an SEC Form 4 filed Oct 2, 2026.
It was an open-market sale.
The trade happened on Sep 30, 2026, 2 days before it was made public.
IRD has moved -5.4% since the trade date, from $4.84 to $4.58 (Oct 2, 2026 close).
- Traded
- Sep 30, 2026
- Disclosed
- Oct 2, 2026
- Filing delay
- 2 days
- Price since
- -5.4%
- Role
- Dir
- Source
- SEC Form 4
More IRD insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.